Inhibition of tumor growth by peptide specific cytotoxic T lymphocytes in a three-dimensional collagen matrix

Journal of Immunological Methods

Volumn 200, Issue 1-2, 1997, Pages 47-54

  Weiz, Wei Zen ^a   Miller, Bonnie ^a   Gutierrez, Richard M ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

antigenic peptide; class I major histocompatibility complex; cytotoxic T lymphocyte; mammary tumor; mouse

Indexed keywords

COLLAGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST TUMOR; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, NEOPLASM; COLLAGEN; CYTOTOXICITY, IMMUNOLOGIC; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0343036152     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(96)00196-2     Document Type: Article

References (15)

1. Davis, M.M. and Bjorkman, P.J. (1988) T-cell antigen receptor genes and T-cell recognition. Nature 334, 395.
2. Fisk, B., Blevins, T.L., Wharton, J.T. and Ioannides, C.G. (1995) Identification of an immunodominant peptide of Her-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. Exp. Med. 181, 2109.
3. Gaugler, B., Van den Eynde, B., Van der Bruggen, P., Romero, P., Gaforio, J.J., De Plaen, E., Lethe, B., Brasseur, F. and Boon, T. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921.
4. d binding peptides and induction of peptide specific CTL. J. Immunol. Methods 176, 245.
5. Gunzburg, W.H., Teinemann, F., Wintersperger, S., Miethke, T., Wagner, H., Erfle, V. and Salmons, B. (1993) Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364, 154.
6. Mahoney, K.H., Miller, B.E. and Heppner, G.H. (1985) FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor associated macrophages from metastatic and non-metastatic mouse mammary tumors. J. Leukocyte Biol. 38, 573,
7. Marks, T.A., Woodman, R.J., Geran, R.I., Billups, L.H. and Madison, R.M. (1977) Characterization on responsiveness of the Madison 109 lung carcinoma to various antitumor agents. Cancer Treat. Rep. 61, 1459.
8. Miller, B.E., Miller, F.R. and Heppner, G.H. (1984) Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions. J. Cell Physiol. 3 (suppl.), 105.
9. Monaco, J.J. (1992) Pathways of antigen processing: A molecular model of MHC class-I-restricted antigen processing. Immunol. Today 13, 173.
10. Peoples, G.E., Goedegebuure, P.S., Smith, R. Linehan, D.C., Yoshino, I. and Eberlein, T.J. (1995) Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same Her-2/neu-derived peptide. Proc. Natl. Acad. Sci. USA 92, 432.
11. Ratner, S., Patrick, P. and Bora, G. (1992) Lymphocyte development of adherence and motility in extracellular matrix during IL-2 stimulation. J. Immunol. 149, 681.
12. Wei, W.Z., Massey, R.J. and Heppner, G.H. (1985) A 3-dimensional tumor growth inhibition assay for testing monoclonal antibody cytotoxicity. Cancer Immunol. Immunother. 20, 137.
13. Wei, W.Z., Gill, R.F. and Wang, H. (1993) Mouse mammary tumor virus associated antigens and superantigens-immunomolecular correlates of neoplastic progression. Sem. Cancer Biol. 4, 205.
14. d-restricted immunogenic peptide. Int. J. Cancer 66, 1.
15. Wilkinson, P.C. (1986) The locomotor capacity of human lymphocytes and its enhancement by cell growth. Immunology 57, 281.